| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |